These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6363373)

  • 21. New cirramycin-family antibiotics F-1 and F-2. Selection of producer mutants, fermentation, isolation, structural elucidation and antibacterial activity.
    Sawada Y; Tsuno T; Miyaki T; Naito T; Oki T
    J Antibiot (Tokyo); 1989 Feb; 42(2):242-53. PubMed ID: 2925516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation, characterization and structures of PA-46101 A and B.
    Matsumoto M; Kawamura Y; Yoshimura Y; Terui Y; Nakai H; Yoshida T; Shoji J
    J Antibiot (Tokyo); 1990 Jul; 43(7):739-47. PubMed ID: 2387767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Activity dynamics of potential marker enzymes of Serratia marcescens cytoplasm and periplasm].
    Bogomol'naia LM; Filimonova MN
    Prikl Biokhim Mikrobiol; 2010; 46(4):428-32. PubMed ID: 20873166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piper betle and its bioactive metabolite phytol mitigates quorum sensing mediated virulence factors and biofilm of nosocomial pathogen Serratia marcescens in vitro.
    Srinivasan R; Devi KR; Kannappan A; Pandian SK; Ravi AV
    J Ethnopharmacol; 2016 Dec; 193():592-603. PubMed ID: 27721053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics produced by mutants of Streptomyces caelestis. I. 7-O-demethylcelesticetin and its degradation products.
    Argoudelis AD; Coats JH; Lemaux PG; Sebek OK
    J Antibiot (Tokyo); 1972 Aug; 25(8):445-55. PubMed ID: 4648486
    [No Abstract]   [Full Text] [Related]  

  • 26. Biodegradation of 1,1,1-trichloro-2,2-bis(4-chlorophenyl) ethane (DDT) by using Serratia marcescens NCIM 2919.
    Grewal J; Bhattacharya A; Kumar S; Singh DK; Khare SK
    J Environ Sci Health B; 2016 Dec; 51(12):809-816. PubMed ID: 27494385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sensitivity of Serratia marcescens to chemotherapy].
    Neguţ M; Niţulescu A; Potcoavă R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(1):27-36. PubMed ID: 349661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial production of 2,3-butanediol by a newly-isolated strain of Serratia marcescens.
    Shi L; Gao S; Yu Y; Yang H
    Biotechnol Lett; 2014 May; 36(5):969-73. PubMed ID: 24375234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular nitrogenous metabolits in Serratia marcescens.
    Marx A; Sendrea M; Petcovici M
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):183-6. PubMed ID: 4936236
    [No Abstract]   [Full Text] [Related]  

  • 30. (1)H, (13)C and (15)N resonance assignments of the C-terminal domain of HasB, a specific TonB like protein, from Serratia marcescens.
    Lefèvre J; Simenel C; Delepelaire P; Delepierre M; Izadi-Pruneyre N
    Biomol NMR Assign; 2007 Dec; 1(2):197-9. PubMed ID: 19636864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical characteristics and antibiotic susceptibilities of Serratia marcescens isolated from clinical specimens.
    Chong Y; Yi KN; Lee SY
    Yonsei Med J; 1978; 19(1):32-8. PubMed ID: 382648
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure of a neutral polymer isolated from the lipopolysaccharide of Serratia marcescens O1 (strain C.D.C. 866-57).
    Furn S; Wilkinson SG
    Carbohydr Res; 1985 Jun; 139():293-7. PubMed ID: 3896489
    [No Abstract]   [Full Text] [Related]  

  • 33. Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08.
    Tarcsay L; Wang CS; Li SC; Alaupovic P
    Biochemistry; 1973 May; 12(10):1948-55. PubMed ID: 4350107
    [No Abstract]   [Full Text] [Related]  

  • 34. Study of ChiR function in Serratia marcescens and its application for improving 2,3-butanediol from crystal chitin.
    Yan Q; Hong E; Fong SS
    Appl Microbiol Biotechnol; 2017 Oct; 101(20):7567-7578. PubMed ID: 28884384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron acquisition from heme and hemoglobin by a Serratia marcescens extracellular protein.
    Létoffé S; Ghigo JM; Wandersman C
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9876-80. PubMed ID: 7937909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efflux systems in Serratia marcescens].
    Mardanova AM; Bogomol'naia LM; Romanova IuD; Sharipova MR
    Mikrobiologiia; 2014; 83(1):3-14. PubMed ID: 25423729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on production and biological potential of prodigiosin by Serratia marcescens.
    Suryawanshi RK; Patil CD; Borase HP; Salunke BK; Patil SV
    Appl Biochem Biotechnol; 2014 Jul; 173(5):1209-21. PubMed ID: 24781979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of different sodium chloride concentrations on certain aspects of Serratia marcescens bacteria metabolism].
    Kogan IB; Berlovskaia TI
    Mikrobiologiia; 1973; 42(6):1052-7. PubMed ID: 4592947
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and characterization of nanoparticles conjugated tannase and using it for enhancement of antibacterial activity of tannase produced by Serratia marcescens.
    Nsayef Muslim DS; Abbas Dham Z; J Mohammed DN
    Microb Pathog; 2017 Sep; 110():484-493. PubMed ID: 28735079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.